CD86 and neoplasm: Strikingly, untreated A375s yield HMDMs exhibiting a tumor-associated macrophage phenotype characterized by CD40, CD80, and CD206 surface expression while injured A375s yield HMDMs with markers of increased antigen presentation, namely HLADR and CD86.